Interaction of beta-adrenergic blocking agents with noradrenaline in vascular smooth muscle.
D000083:Acetanilides / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001011:Aorta / Q000187:drug effects; D002396:Catechols / Q000494:pharmacology; D004336:Drug Antagonism; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects*; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D010636:Phenols / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011817:Rabbits; D011984:Sensory Receptor Cells / Q000187:drug effects; D013565:Sympatholytics / Q000494:pharmacology*
D000083:Acetanilides; D000605:Amino Alcohols; D002396:Catechols; D010636:Phenols; D013565:Sympatholytics; D010643:Phenoxybenzamine; D000804:Angiotensin II; D009638:Norepinephrine